Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Stoops

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|August 6, 2024
Discovery of <i>gem</i>-Dimethyl-hydroxymethylpyridine Derivatives as Potent Non-nucleoside RSV Polymerase InhibitorsSandrine Grosse, Ludwig Cooymans, Werner Embrechts, et al.
Journal of Medicinal Chemistry|July 3, 2018
2,4-Diaminoquinazolines as Dual Toll-like Receptor (TLR) 7/8 Modulators for the Treatment of Hepatitis B VirusWerner Embrechts, Florence Herschke, Frederik Pauwels, et al.
Journal of Medicinal Chemistry|March 14, 2024
Discovery of JNJ-1802, a First-in-Class Pan-Serotype Dengue Virus NS4B InhibitorBart Kesteleyn, Jean-François Bonfanti, Dorothée Bardiot, et al.
Journal of Medicinal Chemistry|June 30, 2023
Discovery of Acyl-Indole Derivatives as Pan-Serotype Dengue Virus NS4B InhibitorsBart Kesteleyn, Dorothée Bardiot, Jean-François Bonfanti, et al.
Plos Pathogens|May 5, 2026
An orthoflavivirus inhibitor targeting multifunctional NS2A protein, a previously unidentified targetDoortje Borrenberghs, Kitti Wing Ki Chan, Sven Van Brandt, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2012
Design and synthesis of HIV-1 protease inhibitors for a long-acting injectable drug applicationBart Kesteleyn, Katie Amssoms, Wim Schepens, et al.
Nature|October 7, 2021
A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interactionSuzanne J F Kaptein, Olivia Goethals, Dominik Kiemel, et al.
Nature|October 21, 2021
Publisher Correction: A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interactionSuzanne J F Kaptein, Olivia Goethals, Dominik Kiemel, et al.
Journal of Medicinal Chemistry|July 4, 2017
Identification and Optimization of Pyrrolo[3,2-d]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis BDavid C McGowan, Florence Herschke, Frederik Pauwels, et al.
Journal of Medicinal Chemistry|June 27, 2024
Spiro-Azetidine Oxindoles as Long-Acting Injectables for Pre-Exposure Prophylaxis against Respiratory Syncytial Virus InfectionsBart Kesteleyn, Florence Herschke, Nicolas Darville, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|August 6, 2024
Discovery of <i>gem</i>-Dimethyl-hydroxymethylpyridine Derivatives as Potent Non-nucleoside RSV Polymerase InhibitorsSandrine Grosse, Ludwig Cooymans, Werner Embrechts, et al.
Journal of Medicinal Chemistry|July 3, 2018
2,4-Diaminoquinazolines as Dual Toll-like Receptor (TLR) 7/8 Modulators for the Treatment of Hepatitis B VirusWerner Embrechts, Florence Herschke, Frederik Pauwels, et al.
Journal of Medicinal Chemistry|March 14, 2024
Discovery of JNJ-1802, a First-in-Class Pan-Serotype Dengue Virus NS4B InhibitorBart Kesteleyn, Jean-François Bonfanti, Dorothée Bardiot, et al.
Journal of Medicinal Chemistry|June 30, 2023
Discovery of Acyl-Indole Derivatives as Pan-Serotype Dengue Virus NS4B InhibitorsBart Kesteleyn, Dorothée Bardiot, Jean-François Bonfanti, et al.
Plos Pathogens|May 5, 2026
An orthoflavivirus inhibitor targeting multifunctional NS2A protein, a previously unidentified targetDoortje Borrenberghs, Kitti Wing Ki Chan, Sven Van Brandt, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2012
Design and synthesis of HIV-1 protease inhibitors for a long-acting injectable drug applicationBart Kesteleyn, Katie Amssoms, Wim Schepens, et al.
Nature|October 7, 2021
A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interactionSuzanne J F Kaptein, Olivia Goethals, Dominik Kiemel, et al.
Nature|October 21, 2021
Publisher Correction: A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interactionSuzanne J F Kaptein, Olivia Goethals, Dominik Kiemel, et al.
Journal of Medicinal Chemistry|July 4, 2017
Identification and Optimization of Pyrrolo[3,2-d]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis BDavid C McGowan, Florence Herschke, Frederik Pauwels, et al.
Journal of Medicinal Chemistry|June 27, 2024
Spiro-Azetidine Oxindoles as Long-Acting Injectables for Pre-Exposure Prophylaxis against Respiratory Syncytial Virus InfectionsBart Kesteleyn, Florence Herschke, Nicolas Darville, et al.
Pageof 4